A randomized phase III, factorial design, of cabazitaxel and pelvic radiotherapy in patients with localized prostate cancer and high-risk features of relapse: The PEACE 2 trial from Unicancer

Por: Blanchard, P, Foulon, S, Artignan, X, Carles, J, Ronchin, P, Gizzi, M, Freixa, SV, Valdagni, R, Sargos, P, Da Costa, LAM, Duberge, T, Guillot, A, Latorzeff, I, Gallardo, E, Saez, MI, Abadie-Lacourtoisie, S, Bennamoun, M, Hasbini, A, Tantot, F and Fizazi, K

---

Publicada: 1 sep 2021 Ahead of Print: 1 sep 2021

---

---

Filiaciones:
Blanchard, P:
 Inst Gustave Roussy, Radiat Oncol, Villejuif, France

Foulon, S:
 Gustave Roussy, Biostat & Epidemiol Off, Canc Campus, Villejuif, France

Artignan, X:
 CHP St Gregoire, Oncol, St Gregoire, France

Carles, J:
 Vall Hebron Univ Hosp, Genitourinary Oncol, Barcelona, Spain

Ronchin, P:
 Ctr Azureen Cancerol, Radiotherapy, Mougins, France

Gizzi, M:
 GHdC Grand Hop Charleroi, Dept Med Oncol, Site Notre Dame, Charleroi, Belgium

:
 Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Radiat Oncol, Badalona, Spain

Valdagni, R:
 Inst Nazl Tumori Milano Fdn IRCCS, Radiotherapy, Milan, Italy

Sargos, P:
 Inst Bergonie, Radiotherapy, Bordeaux, France

Da Costa, LAM:
 CHU Lisboa Norte EPE, HSM Hosp Santa Maria, Dept Oncol, Lisbon, Portugal

Duberge, T:
 Ctr Radiotherapie St Louis Croix Rouge Francaise, Radiotherapy, Toulon, France

Guillot, A:
 Neuwirth Canc Ctr, Oncol, St Priest, France

Latorzeff, I:
 Clin Pasteur, Radiat Oncol, Toulouse, France

Gallardo, E:
 Hosp Univ, Inst Invest & Innovacio Parc Tauli, Dept Med Oncol, Sabadell, Spain

Saez, MI:
 Hosp Univ Virgen Victoria, Dept Med Oncol, Malaga, Spain

Abadie-Lacourtoisie, S:
 Inst Cancerol Ouest, Oncol Med Gynecol, Angers, France

Bennamoun, M:
 Inst Mutualiste Montsouris, Oncol, Paris, France

Hasbini, A:
 Clin Pasteur, Oncol, Brest, France

Tantot, F:
 Unicancer, R&D, Paris, France

Fizazi, K:
 Inst Gustave Roussy, Dept Canc Med, Villejuif, France